major-depressive-disorder

Documents about major-depressive-disorder

• Adherence to the ultra-processed dietary pattern and risk of depressive outcomes: Findings from the NutriNet Brasil cohort study and an updated systematic review and meta-analysis#218027HAL (France)
• Validation of the Brief Children's Depression Rating Scale in Children Treated With Selegiline Transdermal Patch vs Placebo#5531Europe PMC
• Safety, tolerability, and preliminary efficacy of seltorexant versus quetiapine extended release as adjunctive therapy in major depressive disorder: a randomized, flexible-dose, 6-month, parallel-group, exploratory study.#8980NCBI PubMed Central
• Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal Thoughts#826548ClinicalTrials.gov
• Remotely Non-invasive Brain Stimulation and Videogame to Alleviate Depression#860921ClinicalTrials.gov
• Enhancing Operational Readiness With Digital Self-Managed Cognitive Behavioral Therapy for Insomnia (CBTI)#860969ClinicalTrials.gov
• Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects#905146ClinicalTrials.gov
• First-In-Human (FIH), Single Ascending Dose (SAD) Study of FluoroEthylNorMemantine (FENM)#916380ClinicalTrials.gov
• Extended Effects of Cannabis Abstinence on Clinical Symptoms and Cognition in Depression#918857ClinicalTrials.gov
• Serotonin transporter polymorphism (5-HTTLPR) is associated with post-awakening cortisol measures in previous depression#651798Europe PMC
• Safety and Tolerability of Adjunctive Lumateperone for the Treatment of Major Depressive Disorder: A Pooled Analysis of Two Randomized Placebo-Controlled Trials#680892Springer Nature OA
• A Phase 1 Study To Investigate The Pharmacokinetics, Safety And Tolerability Of CP-601,927 In Healthy Japanese Subjects#800192ClinicalTrials.gov
• Movement for Depression - An RCT Assessing the Effects of Physical Activity Promotion for People With MDD#857761ClinicalTrials.gov
• Using Electrophysiology to Index Non-invasive Brain Stimulation Effects on Reward System Functioning in Depression#862498ClinicalTrials.gov
• Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept#909245ClinicalTrials.gov
• Impact of Anxiety and Depression on Implicit and Explicit Memory Performance#1033718ClinicalTrials.gov
• Clock gene influences on sleep quality and HPA axis in major depressive disorder#311376Dipòsit Digital de la Universitat de Barcelona
• A Data-Driven Closed-Loop Control Approach to Drive Neural State Transitions for Mechanistic Insight#642336Europe PMC
• AI-Guided CBT for Depression and Anxiety#836692ClinicalTrials.gov
• tDCS as Adjunctive Therapy to Cognitive Stimulation in Medical Students With Depression#869504ClinicalTrials.gov
• Mindfulness-Based Cognitive Therapy Effect on Depression and C-Reactive Protein Levels After 8 Weeks of Treatment#888785ClinicalTrials.gov
• The Medically Tailored Groceries and Mental Health Study#916810ClinicalTrials.gov
• Domain specificity and magnitude of cognitive-psychosocial associations in major depressive disorder: A systematic review and meta-analytic approach with multilevel sensitivity analyses#203544ULRR
• A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment#807243ClinicalTrials.gov
• Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration#812454ClinicalTrials.gov
• A Precision Medicine Approach to the Prevention of Depression in Patients With Atrial Fibrillation#885982ClinicalTrials.gov
• Effects of rTMS Compared to SSRI as Early Treatment of Depression (Early-TMS)#888261ClinicalTrials.gov
• The WORKER Study: Escitalopram and Telephone-based Cognitive Behaviour Therapy (CBT) for Depressed Working People#914744ClinicalTrials.gov
• Multi-site Feasibility of an Integrated Treatment for the Biology and Experience of Depression: The MULTIBED Study#993236ClinicalTrials.gov
• State, Trait and Recovery-Related Differences in Reinforcement Learning and Value-Based Decision Making in Major Depressive Disorder#355579OSF
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior#832821ClinicalTrials.gov
• Linear Asymmetric rTMS in Adolescent Treatment-Resistant Depression: Tolerability of Treatment Durations Ranging From Ten Days to One Day#858496ClinicalTrials.gov
• A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD#876204ClinicalTrials.gov
• A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.#1010774ClinicalTrials.gov
• Efficacy and Safety of Lumateperone and Other Atypical Antipsychotics Approved as Adjunctive Treatment for Major Depressive Disorder in the United States: A Network Meta-Analysis#479677Springer Nature OA
• The Efficacy of Long-Chain Fatty Acids, Eicosapentaenoic Acid (EPA) and Specialized Pro-Resolving Mediators (SPMs), in Treating Long COVID Neuropsychiatric Symptoms#864565ClinicalTrials.gov
• A Randomized Controlled Trial of Robotic Support for Enhanced Later Life (RoSELL)#901792ClinicalTrials.gov
• An Energetic View on Creativity, Psychopathology and Intelligence: The Brain2Business Study#979838ClinicalTrials.gov
• Multisystem resiliency moderates the major depression–Telomere length association: Findings from the Heart and Soul Study#642244eScholarship
• Multimodal Magnetic Resonance Imaging-based Study of Electroconvulsive Efficacy Prediction in Adolescents With Depression: a Multicenter Prospective Cohort Study#833137ClinicalTrials.gov
• Optimizing Outcomes of Treatment-Resistant Depression in Older Adults#1009466ClinicalTrials.gov
• Intervention to Reduce HIV Related Stigma Among Pregnant and Postpartum Women#969121ClinicalTrials.gov
• Acquisition and Analysis of Relationships Between Longitudinal Emotional Signals Produced by an Artificial Intelligence Algorithm and Self-questionnaires Used in the Psychiatric Follow-up of Patients With Mood and/or Anxiety Disorders: a Real-Environment Study.#856495ClinicalTrials.gov
• Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study#612097eScholarship
• The Effect of Mindfulness in Inflammation Markers (MLR, NLR, PLR), Stress, Anxiety, and Depression Rate Among Survivors of Tidal Flooding in Sayung Demak#903023ClinicalTrials.gov
• The role of sphingolipids in major depressive disorder and associated cognitive impairment: interactions with monoaminergic signaling, neuroinflammation, and neurogenesis / Nicolas HOERTEL, Christiane MÜHLE, Christian P. MÜLLER, Hédi CHAIEB, Valentin Scheer, Mahdi FAYAD, Marina SÁNCHEZ-RICO, Frédéric LIMOSIN, Johannes KORNHUBER#983091Deutsche Nationalbibliothek
• Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System#806326ClinicalTrials.gov
• COpenhagen Magnetic Personalized Accelerated Brain Circuit Therapy for Treatment Resistant Depression#903514ClinicalTrials.gov
• Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study#870522ClinicalTrials.gov
• Suicide risk and prevalence of major depressive disorder (MDD) among individuals infected with HIV-1 subtype C versus B in Southern Brazil#612041eScholarship